M&A Deal Summary

Wacker Chemie Acquires Wacker Leon

On May 8, 2023, Wacker Chemie acquired life science company Wacker Leon from Kartesia for 100M EUR

Acquisition Highlights
  • This is Wacker Chemie’s 1st transaction in the Life Science sector.
  • This is Wacker Chemie’s 0th largest (disclosed) transaction.
  • This is Wacker Chemie’s 1st transaction in Spain.

M&A Deal Summary

Date 2023-05-08
Target Wacker Leon
Sector Life Science
Buyer(s) Wacker Chemie
Sellers(s) Kartesia
Deal Type Add-on Acquisition
Deal Value 100M EUR

Target

Wacker Leon

Leon, Spain
Wacker Leon is a Bio-pharma manufacturing company that develops, manufactures, sells and distributes a broad range of pharmaceutical products, focusing on Active Pharmaceutical Ingredients ("APIs") for penicillin-based antibiotics. Wacker Leon was founded in 1954 and is based in Leon, Spain.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Wacker Chemie

Munich, Germany

Category Company
Founded 1914
Sector Chemicals
Employees16,425
Revenue 5.7B EUR (2024)
DESCRIPTION

Wacker Chemie is a provider of specialty chemical products worldwide. Wacker Chemie was founded in 1914 and is based in Munich, Germany.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Spain M&A 1 of 1
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-25 Electroschmelzwerk Kempten AG

Munich, Germany

ESK (then known as Electroschmelzwerk Kempten AG) was founded in 1922 to produce non-oxide powders and technical ceramics.

Sell $118M

Seller(S) 1

SELLER

Kartesia

Investor Investor Investor Investor Investor


Category Lender
Founded 2013
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Kartesia is a private investment group and lender that looks to invest in lower middle-market companies throughout the European Union and Central Europe. The Firm is industry agnostic and seeks to commit €10 to €100 million in profitable companies with at least €5 million of EBITDA. Proceeds are typically invested alongside sponsors to support buyouts, recapitalizations, shareholder liquidity needs, or restructurings. Kartesia was established in 2013 and is headquartered in London.


DEAL STATS #
Overall 4 of 9
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Spain M&A 1 of 2
Year: 2023 M&A 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-29 Optegra

London, United Kingdom

Optegra is an eye healthcare provider treating A-Z eye conditions that is supported by dedicated optometrists, healthcare technicians and consultants who provide a wide range of procedures including lens replacement (Clarivu), laser eye surgery, cataract removal, glaucoma, and AMD. Optegra was founded in 2007 and is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-26 Green Mobility

Munich, Germany

Green Mobility is a technology-based e-bike leasing groups. Green Mobility is based in Munich, Germany.

Buy -